시장보고서
상품코드
1320173

세계의 케타민 클리닉 시장 : 치료별, 치료법별, 소개원별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Ketamine Clinics Market with COVID-19 Impact Analysis, By Treatment, By Therapy, By Referral Source, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 333 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

케타민 클리닉(Ketamine Clinics) 시장 규모는 2022년 87억 450만 달러였으며, 2023년부터 2030년까지 CAGR 11.3%로 추이하며 확대될 것으로 예상됩니다.

케타민 클리닉 시장 - 시장 역학 :

조사·임상시험과 케타민 수요 증가가 시장 성장을 뒷받침

정신질환의 유병률 증가와 기존의 치료법의 한계가 함께 케타민 등의 대체치료에 대한 수요가 높아지고 있습니다. 또한, 초기 연구는 긍정적인 결과를 얻었기 때문에 정신 위생 우려의 치료에 대한 케타민의 장기적인 안전성과 효능을 결정하기 위해 더 많은 임상시험과 조사가 필요합니다. 또한, 연구가 진행됨에 따라 치료 옵션으로 케타민에 대한 견해와 받아들이는 방법이 바뀔 수 있습니다. 또한, 케타민 치료이 인지됨에 따라 기존 클리닉과 정신과 클리닉 중 일부는 케타민 치료을 제품 라인업의 일부에 추가하기 시작했습니다. 그러나 케타민 치료에 대한 보험 적용은 큰 과제가 될 수 있으며, 이는 예측 기간 동안 케타민 클리닉 시장 성장을 억제 할 수 있습니다.

케타민 클리닉 시장 - 주요 통찰 :

  • 케타민 클리닉 산업은 정신 건강 상태의 유병률의 상승과 기존의 치료법의 한계에 의해 상당한 속도로 성장할 것으로 예측됩니다.
  • 치료 세분화에 근거하면, 현장 치료이 가까운 미래에 최대 시장 점유율을 나타낼 것으로 예측됩니다.
  • 치료 세분화에 근거하면, 우울증이 2022년의 주요 유형이었습니다.
  • 지역별로는 북미가 2022년의 주요 수익원이었습니다.

케타민 클리닉 시장 - 세분화 분석 :

세계의 케타민 클리닉 시장은 치료, 치료법, 소개원, 지역에 따라 세분화됩니다.

시장은 치료에 따라 세가지 범주로 나뉩니다. 불안, 우울증, PTSD 등 입니다. 우울증 분야는 심각한 우울증을 앓고 있는 성인이 증가하고 있기 때문에 최대 판매 점유율을 차지할 것으로 보입니다. 또한 의학계에서 케타민은 우울증 치료에 사용될 수 있다고 주목을 받고 있습니다. 또한, 케타민 클리닉은 우울증 및 기타 기분 장애로 고통받는 환자에게 케타민 치료을 제공하는 전문센터로 출현합니다.

시장은 치료법별로 온라인 치료와 현장 치료의 두 가지로 분류됩니다. 예측 기간 동안 시장 점유율을 차지하는 것은 현장 치료입니다. 정신 질환의 경우, 케타민 치료의 수용 확대가 케타민의 확대로 이어지고, 또한 같은 부문의 성장을 견인하고 있습니다. 또한, 카운슬러, 심리학자, 정신과 의사 등 정신 위생 전문가도 환자에게 치료 세션을 제공합니다.

시장은 1차 진료의사, 온라인 광고, 정신건강 전문가라는 소개원을 기반으로 하는 3가지 범주로 나뉩니다. 1차 진료의 부문은 시장 점유율을 독점할 것으로 예상됩니다. PCP는 불안 장애와 우울증과 같은 정신 건강 장애와 같은 수많은 병리를 진단하고 치료하는 데 적합합니다. 또한, 1차 진료의가 케타민 치료이 심각하거나 치료 저항성 우울증 및 기타 정신 위생 우려에 도움이 될 수 있다고 생각하는 경우, 일차 진료의는 케타민 치료이 심한 우울증 또는 치료 저항성 우울증이나 기타 정신 건강상의 우려에 도움이 될 수 있다고 생각하면 환자를 케타민 클리닉에 보낼 수 있습니다. 이러한 요인은 같은 부문의 성장을 가속시킬 수 있습니다.

케타민 클리닉 시장 - 지역적 통찰력 :

지역적으로, 이 시장은 북미, 남미, 유럽, 아시아 태평양, 중동 및 아프리카로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가별로 더 나뉩니다.

케타민 임상 시장 - 경쟁 구도 :

이 시장은 지속적인 오피오이드 위기, 정신 건강 인식 증가, 전 세계의 수많은 케타민 클리닉을 포함한 요인에 의해 상당한 성장을 목격하고 있습니다. 또한 케타민 클리닉 업계는 전 세계적으로 시장 입지를 확대하기 위해 파트너십, 새로운 서비스 출시, 인수합병, 확장 등 다양한 전략에 집중하고 있습니다. 또한 더 많은 공급자가이 공간에 진입함에 따라 케타민 클리닉 시장은 더욱 경쟁이 치열 해졌습니다. 예를 들어, 2023년 4월, 마인드블룸은 SHIFT와 파트너십을 체결하여 직원들에게 재택 케타민 치료 혜택을 제공한다고 발표했습니다. 또한, 이 파트너십을 통해 모든 SHIFT 직원은 마인드블룸을 통해 정상 가격보다 훨씬 저렴한 가격으로 재택 케타민 치료를 받을 수 있게 됩니다.

목차

제1장 케타민 클리닉 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 케타민 클리닉 주요 시장 동향

  • 케타민 클리닉 시장 성장 촉진 요인
  • 케타민 클리닉 시장 성장 억제 요인
  • 케타민 클리닉 시장 기회
  • 케타민 클리닉 시장 향후 동향

제4장 케타민 클리닉 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 프레임워크 분석

제5장 케타민 클리닉 시장 : COVID-19 영향 분석

  • COVID-19 이전 영향 분석
  • COVID-19 이후 영향 분석

제6장 케타민 클리닉 시장 상황

  • 케타민 클리닉 시장 점유율 분석(2022년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 케타민 클리닉 시장 - 치료별

  • 개요
    • 치료별 부문 점유율 분석
    • 불안
    • 우울증
    • PTSD
    • 기타

제8장 케타민 클리닉 시장 - 치료법별

  • 개요
    • 치료법별 부문 점유율 분석
    • 온라인 치료
    • 현장 치료

제9장 케타민 클리닉 시장 - 소개원별

  • 개요
    • 소개원별 부문 점유율 분석
    • 1차 진료의
    • 온라인 광고
    • 정신건강 전문가

제10장 케타민 클리닉 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아 태평양(APAC)
    • 개요
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 남미
    • 개요
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석-케타민 클리닉 산업

  • 경쟁 대시보드
  • 기업 개요
    • Arevipharma GmbH
    • Biotechnica Pharma Global(BPG)
    • NY Ketamine Infusions
    • Core One Labs
    • Johnson &Johnson
    • Pfizer
    • Field Trip Health and Wellness Ltd.
    • Save Minds
    • Ember
    • UQUIFA
    • Mindbloom
    • Ketamine Clinics
    • Vitalitas Denver Ketamine Clinic

제12장 애널리스트의 전방위 전망

LYJ 23.08.21

REPORT HIGHLIGHT

Ketamine clinics market size was valued at USD 8,704.5 Million in 2022, expanding at a CAGR of 11.3% from 2023 to 2030.

Ketamine clinics are defined as hospitals that engage in therapeutic purposes by administering ketamine, a dissociative anesthetic, and analgesic drug. Moreover, as a potential treatment ketamine has drawn interest for numerous mental health conditions, especially anxiety disorders, post-traumatic stress disorder (PTSD), and treatment-resistant depression. In line with this, ketamine has shown promise in offering quick relief, generally within hours, while traditional antidepressant medications may require weeks or months to show results. Furthermore, ketamine clinics traditionally provide intravenous (IV) ketamine infusions or, in other cases, other forms of ketamine administration, including oral lozenges and nasal sprays.

Ketamine Clinics Market- Market Dynamics:

Research & Clinical Trials and Increasing Demand Ketamine will boost the market growth

The increasing prevalence of mental health conditions coupled with limitations of traditional treatments, in turn; there has been a rising demand for alternative therapies such as ketamine. Moreover, with the positive outcomes in early studies, more clinical trials and investigation is required to determine the long-term safety and effectiveness of ketamine for the treatment of mental health concern. In addition, as research develops the view and acceptance of ketamine as a treatment option may shift. Furthermore, some established medical practices and mental health clinics have started including ketamine treatment as part of their product line, as ketamine therapy gains more recognition. However, insurance coverage for ketamine therapy can be a major challenge, which may restrain the ketamine clinic's market growth over the forecast period.

Ketamine Clinics Market- Key Insights:

  • As per the analysis shared by our research analyst, the ketamine clinics market is estimated to grow annually at a CAGR of around 11.3% over the forecast period (2023-2030)
  • The ketamine clinics industry is projected to grow at a significant rate due to the rising prevalence of mental health conditions and limitations of traditional treatments
  • Based on therapy segmentation, on-site therapy was predicted to show maximum market share in the near future
  • Based on treatment segmentation, depression was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Ketamine Clinics Market- Segmentation Analysis:

The global ketamine clinics market is segmented on the basis of treatment, therapy, referral source, and region.

The market is divided into three categories based on treatment: anxiety, depression, PTSD, and others. The depression segment is likely to possess the largest revenue share owing to the growing number of adults with severe major depression. Additionally, in the medical community ketamine has gained attention for its potential use in treating depression. Moreover, ketamine clinics have emerged as specialized centers that provide ketamine therapy for patients who have suffered from depression or other mood disorders.

The market is divided into two categories based on therapy: online therapy and on-site therapy. The on-site therapy segment is likely to possess the market share over the forecast period. For mental health disorders increasing acceptance of ketamine therapy is led to an expansion of ketamine, further driving the segment growth. Additionally, mental health professionals also provide therapy sessions for patients including counselors, psychologists, and psychiatrists.

The market is divided into three categories based on referral sources: primary care physicians, online advertising, and mental health professionals. The primary care physicians segment is expected to dominate the market share. PCPs are suitable to diagnose and treat numerous medical conditions, such as mental health disorders like anxiety and depression. Moreover, primary care physicians may send their patients to ketamine clinics when primary care physicians think ketamine therapy might be helpful for severe or treatment-resistant depression or other mental health concerns. Thereby such factors may propel the segment growth.

Ketamine Clinics Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Ketamine Clinics Market- Competitive Landscape:

The market is witnessing significant growth, driven by factors including the ongoing opioid crisis, rising mental health awareness, and a large number of ketamine clinics across the globe. Moreover, ketamine clinics industries are focusing on numerous strategies such as partnerships, launching new services, mergers & acquisitions, and expansions to expand their market presence worldwide. Furthermore, as more providers have entered the space the ketamine clinics market has become more competitive. For instance, in April 2023, Mindbloom announced a partnership with SHIFT to provide at-home ketamine therapy as a benefit to its employees. Additionally, through this partnership, all SHIFT employees will have access to at-home ketamine therapy for a fraction of the normal price through Mindbloom.

Recent Developments:

For instance, in January 2022, Delic Holdings Corp announced its subsidiary, Ketamine Wellness Centers (KWC), has officially expanded operations into Utah with the opening of its Salt Lake City location.

Key features of the study:

  • This proposed research study on ketamine clinics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the ketamine clinics market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for ketamine clinics market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the ketamine clinics market.
  • Impact of COVID-19 on ketamine clinics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on ketamine clinics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the ketamine clinics market, we have also included competitive landscape and key innovator analysis for the ketamine clinics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the ketamine clinics market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global ketamine clinics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL KETAMINE CLINICS MARKET KEY PLAYERS

  • Arevipharma GmbH
  • Biotechnica Pharma Global (BPG)
  • NY Ketamine Infusions
  • Core One Labs
  • Johnson & Johnson
  • Pfizer
  • Field Trip Health and Wellness Ltd.
  • Save Minds
  • Ember
  • UQUIFA
  • Mindbloom
  • Ketamine Clinics
  • Vitalitas Denver Ketamine Clinic

GLOBAL KETAMINE CLINICS MARKET, BY TREATMENT

  • Anxiety
  • Depression
  • PTSD
  • Others

GLOBAL KETAMINE CLINICS MARKET, BY THERAPY

  • Online Therapy
  • On-Site Therapy

GLOBAL KETAMINE CLINICS MARKET, BY REFERRAL SOURCE

  • Primary Care Physicians
  • Online Advertising
  • Mental Health Professionals

GLOBAL KETAMINE CLINICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ketamine Clinics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ketamine Clinics Market Snippet by Treatment
    • 2.1.2. Ketamine Clinics Market Snippet by Therapy
    • 2.1.3. Ketamine Clinics Market Snippet by Referral Source
    • 2.1.4. Ketamine Clinics Market Snippet by Country
    • 2.1.5. Ketamine Clinics Market Snippet by Region
  • 2.2. Competitive Insights

3. Ketamine Clinics Key Market Trends

  • 3.1. Ketamine Clinics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ketamine Clinics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ketamine Clinics Market Opportunities
  • 3.4. Ketamine Clinics Market Future Trends

4. Ketamine Clinics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ketamine Clinics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ketamine Clinics Market Landscape

  • 6.1. Ketamine Clinics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ketamine Clinics Market - By Treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
    • 7.1.2. Anxiety
    • 7.1.3. Depression
    • 7.1.4. PTSD
    • 7.1.5. Others

8. Ketamine Clinics Market - By Therapy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy, 2022&2030 (%)
    • 8.1.2. Online Therapy
    • 8.1.3. On-Site Therapy

9. Ketamine Clinics Market - By Referral Source

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Referral Source, 2022&2030 (%)
    • 9.1.2. Primary Care Physicians
    • 9.1.3. Online Advertising
    • 9.1.4. Mental Health Professionals

10. Ketamine Clinics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Ketamine Clinics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Ketamine Clinics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Ketamine Clinics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Ketamine Clinics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Ketamine Clinics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Ketamine Clinics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Arevipharma GmbH
    • 11.2.2. Biotechnica Pharma Global (BPG)
    • 11.2.3. NY Ketamine Infusions
    • 11.2.4. Core One Labs
    • 11.2.5. Johnson & Johnson
    • 11.2.6. Pfizer
    • 11.2.7. Field Trip Health and Wellness Ltd.
    • 11.2.8. Save Minds
    • 11.2.9. Ember
    • 11.2.10. UQUIFA
    • 11.2.11. Mindbloom
    • 11.2.12. Ketamine Clinics
    • 11.2.13. Vitalitas Denver Ketamine Clinic

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제